.avif)
GP73 Test - Liver Cancer Biomarker
The GP73 blood test measures Golgi protein 73, a liver biomarker used to detect liver disease and improve early identification of hepatocellular carcinoma (liver cancer). Early detection can enable prompt treatment and help reduce the risk of progression to cirrhosis, liver failure, or late-stage liver cancer.
AFP Test - Liver Cancer Biomarker
The AFP (alpha‑fetoprotein) blood test measures AFP levels to help screen for liver disease and certain cancers, and in pregnancy to detect potential fetal neural‑tube defects or chromosomal abnormalities. Early detection can prompt timely follow‑up and treatment, helping prevent progression to advanced liver cancer or other serious complications and ensuring earlier care for affected pregnancies.
DCP Test - Liver Cancer Biomarker
The DCP test measures des‑gamma‑carboxy prothrombin (PIVKA‑II) in blood to assess risk and monitor for hepatocellular carcinoma (HCC) in patients with chronic liver disease. By detecting elevated DCP and tracking changes after treatment, it can help catch HCC earlier or identify recurrence—reducing the likelihood of advanced liver cancer and enabling earlier intervention.
.svg)
